Back to search
Ophthalmopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ophthalmopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ophthalmopathy trials you may qualify forThis study compares ocular lipid layer thickness (LLT) measurements obtained from three commonly used clinical diagnostic devices to evaluate their agreement an…
Central vision loss from macular degeneration creates blind spots that impair reading, face recognition, and navigation. Individuals must learn to use periphera…
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and ad…
The purpose of this study is to compare the efficacy and safety of rimegepant to placebo as a preventative treatment for migraine in children and adolescents ≥…
The purpose of this study is to evaluate the long-term visual outcome of the cataract surgery using a large-scale and comprehensive database of high myopic cata…
This study aims to establish a multi-center artificial intelligence model for the accurate calculation of intraocular lens and its clinical application in highl…
This study is a non-randomized, open-label, interventional trial of TearCare® eyelid warming and manual meibomian gland expression in young adults with clinical…
Geographic atrophy (GA) is an advanced form of dry age-related macular degeneration that leads to progressive and irreversible vision loss. The course of visual…
The purpose of this study is to determine whether corneal collagen crosslinking is effective in the treatment of progressive keratoconus.